Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Qi Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-3788-8548; OpenAlex author ID A5100786560. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

  1. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. Co-author DOI 10.1038/s41419-019-2073-4↗
  2. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. Co-author DOI 10.1074/jbc.ra118.003279↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ning Wu · 1 shared paper, 2019 · strength 0.10
  2. Chuanlong Guo · 1 shared paper, 2019 · strength 0.10
  3. Dayong Shi · 1 shared paper, 2019 · strength 0.10
  4. Huaizhi Wang · 1 shared paper, 2019 · strength 0.10
  5. Zhaocai Zhou · 1 shared paper, 2018 · strength 0.07
  6. Min Chen · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.